#nsclc
Precision Oncology in Lung Cancer: Advancing Targeted and Immunotherapy Treatments
Lung cancer remains one of the deadliest malignancies worldwide, with non-small cell lung cancer (NSCLC) accounting for 85% of cases. Advances in precision oncology have transformed treatment by tailoring therapies based on tumor-specific genetic alterations. Molecular Testing & Targeted Therapy Molecular testing, including next-generation sequencing (NGS), helps identify actionable mutations like EGFR, ALK, ROS1, BRAF, MET exon 14, and
Precision Oncology in Lung Cancer: Advancing Targeted and Immunotherapy Treatments
Lung cancer remains one of the deadliest malignancies worldwide, with non-small cell lung cancer (NSCLC) accounting for 85% of cases. Advances in precision oncology have transformed treatment by tailoring therapies based on tumor-specific genetic alterations. Molecular Testing & Targeted Therapy Molecular testing, including next-generation sequencing (NGS), helps identify actionable mutations like EGFR, ALK, ROS1, BRAF, MET exon 14, and









